ended4월 23일· 1 sources
'연타석 흥행' 프리미어파트너스, 4호 바이오펀드 초읽기 [넘버스]
Why it matters
Premier Partners is solidifying its leadership in biotech investment by launching its 4th bio-fund following consecutive successes. Their 'science-centered' due diligence and active portfolio management serve as a benchmark for sustainable venture capital models in the high-risk biotech sector, especially as they align with government incentives for early-stage development.
1
Sources
+0
24h
—
Growth
135d
Active
Premier PartnersBio-fundVenture CapitalK-Bio VaccineScience-centeredAnchor LP